FDA
FDA increases racial and ethnic diversity in clinical trials
FDA issued a draft guidance document for developi...
FDA OCE commentary: Cancer burden facing Asian Americans partly caused by racism
A commentary authored by seven researchers who participated in the FDA Oncology Center of Excellence “Conversations on Cancer,” held July 29, 2021,...
FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know | Bass, Berry & Sims PLC
The United States Food and Drug Administration (FDA) issued draft guidance on April 13, 2022, entitled, “Diversity Plans to Improve Enrollment of P...
FDA issues ambitious new draft guidance to promote clinical trial diversity | Hogan Lovells
FDA recommends the submission of a Plan for all medical products for which an IND submission is required or for which clinical studies are intended...
FDA Recommends Sponsors Submit Plans for Achieving Trial Diversity
…move in the agency’s drive to increase clinical trial participation in minority populations. The agency says it “will evaluate t...
FDA issues draft guidance for increasing racial and ethnic diversity in clinical trials
The FDA today issued a new draft guidance outlining plans for increased diversity in clinical trials in the U.S.
Expanding upon previous guidances ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
